NUTCRACKER Trademark
Trademark Overview
On Wednesday, September 23, 2020, a trademark application was filed for NUTCRACKER with the United States Patent and Trademark Office. The USPTO has given the NUTCRACKER trademark a serial number of 90203658. The federal status of this trademark filing is REGISTERED as of Tuesday, June 1, 2021. This trademark is owned by Nutcracker Therapeutics, Inc.. The NUTCRACKER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; Compiling data for research purposes in the field of medical science and medical consultancy; DNA analysis services for scientific research purposes; Medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the f...
General Information
| Serial Number | 90203658 |
| Word Mark | NUTCRACKER |
| Filing Date | Wednesday, September 23, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 1, 2021 |
| Registration Number | 6371971 |
| Registration Date | Tuesday, June 1, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 16, 2021 |
Trademark Statements
| Goods and Services | Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; Compiling data for research purposes in the field of medical science and medical consultancy; DNA analysis services for scientific research purposes; Medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; and consulting services for others in the field of design, planning, and implementation of clinical trials; Design, engineering, research, development and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; Scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, November 1, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, September 23, 2020 |
| First Use In Commerce Date | Wednesday, September 23, 2020 |
Trademark Owner History
| Party Name | MEDICI THERAPEUTICS, INC. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | BOSTON, MA 02115
US |
| Party Name | Nutcracker Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Emeryville, CA 94608
US |
| Party Name | Nutcracker Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Emeryville, CA 94608
US |
| Party Name | Nutcracker Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Emeryville, CA 94608
US |
Trademark Events
| Event Date | Event Description |
| Saturday, September 26, 2020 | NEW APPLICATION ENTERED |
| Sunday, November 1, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 28, 2020 | TEAS AMENDMENT OF USE RECEIVED |
| Tuesday, December 29, 2020 | USE AMENDMENT FILED |
| Tuesday, December 29, 2020 | AMENDMENT TO USE PROCESSING COMPLETE |
| Wednesday, February 10, 2021 | ASSIGNED TO EXAMINER |
| Thursday, February 11, 2021 | USE AMENDMENT ACCEPTED |
| Thursday, February 11, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 12, 2021 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| Wednesday, February 24, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 16, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 16, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 1, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Monday, June 1, 2026 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, June 3, 2026 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
